{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T20:53:24Z","timestamp":1772916804909,"version":"3.50.1"},"reference-count":93,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.tiv.2011.05.026","type":"journal-article","created":{"date-parts":[[2011,6,5]],"date-time":"2011-06-05T00:17:38Z","timestamp":1307233058000},"page":"1870-1882","source":"Crossref","is-referenced-by-count":36,"title":["High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis"],"prefix":"10.1016","volume":"25","author":[{"given":"F.M.","family":"van de Water","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Havinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.T.","family":"Ravesloot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.J.M.J.","family":"Horbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.G.E.J.","family":"Schoonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2011.05.026_b0005","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1016\/j.febslet.2006.08.061","article-title":"Drug-induced phospholipidosis","volume":"580","author":"Anderson","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tiv.2011.05.026_b0010","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1002\/hep.24290","article-title":"Induction of vesicular steatosis by amiodarone and tetracycline is associated with up-regulation of lipogenic genes in heparg cells","volume":"53","author":"Antherieu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2011.05.026_b0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfl184","article-title":"Determination of phospholipidosis potential based on gene expression analysis in HepG2 cells","volume":"96","author":"Atienzar","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0020","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/15287398009529872","article-title":"Comparative ultrastructural study of rat hepatocytes after treatment with the hypolipidemic agents probucol, clofibrate, and fenofibrate","volume":"6","author":"Barnard","year":"1980","journal-title":"J. Toxicol. Environ. Health"},{"key":"10.1016\/j.tiv.2011.05.026_b0025","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1600-0773.1980.tb02023.x","article-title":"Zimelidine-induced lipidosis in rats","volume":"47","author":"Bockhardt","year":"1980","journal-title":"Acta Pharmacol. Toxicol. (Copenh)"},{"key":"10.1016\/j.tiv.2011.05.026_b0030","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0300-483X(87)90045-X","article-title":"Amantadine-induced lipidosis. A cytological and physicochemical study","volume":"44","author":"Burmester","year":"1987","journal-title":"Toxicology"},{"key":"10.1016\/j.tiv.2011.05.026_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1023\/A:1024778329320","article-title":"A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development","volume":"19","author":"Casartelli","year":"2003","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0040","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1177\/0192623309352496","article-title":"A strategy for risk management of drug-induced phospholipidosis","volume":"37","author":"Chatman","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9343(85)90346-8","article-title":"Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity","volume":"78","author":"Dake","year":"1985","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tiv.2011.05.026_b0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0021-9150(82)90096-X","article-title":"Light and electron microscopy of liver in hyperlipoproteinemic patients under long-term gemfibrozil treatment","volume":"43","author":"de la Iglesia","year":"1982","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tiv.2011.05.026_b0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0306-4522(79)90001-0","article-title":"Drug-induced experimental lipidosis in the nervous system","volume":"4","author":"Drenckhahn","year":"1979","journal-title":"Neuroscience"},{"key":"10.1016\/j.tiv.2011.05.026_b0060","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0090-9556(25)06154-9","article-title":"Species and dose differences in the accumulation of imipramine by mammalian lungs","volume":"9","author":"Drew","year":"1981","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2011.05.026_b0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/mus.880020105","article-title":"Muscle and nerve changes induced by perhexiline maleate in man and mice","volume":"2","author":"Fardeau","year":"1979","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.tiv.2011.05.026_b0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00690845","article-title":"Differential effects of chloroquine and of several other amphiphilic cationic drugs upon rat choroid plexus","volume":"46","author":"Frisch","year":"1979","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0075","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.etp.2007.01.004","article-title":"Cell-based fluorescence assay for evaluation of new-drugs potential for phospholipidosis in an early stage of drug development","volume":"58","author":"Fujimura","year":"2007","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0080","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0940-9602(11)80404-8","article-title":"Experimentally induced lipidosis in uterine and vaginal epithelium of rats","volume":"176","author":"Geist","year":"1994","journal-title":"Ann. Anat."},{"key":"10.1016\/j.tiv.2011.05.026_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0773.1994.tb01067.x","article-title":"Pentamidine accumulates in rat liver lysosomes and inhibits phospholipid degradation","volume":"74","author":"Glaumann","year":"1994","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0090","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/0006-2952(87)90415-1","article-title":"Influence of cationic amphiphilic drugs on the phosphatidylcholine hydrolysis by phospholipase A2","volume":"36","author":"Grabner","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0095","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0041-008X(71)90108-6","article-title":"Ultrastructural studies of the hepatic changes brought about by Clindamycin and Erythromycin in animals","volume":"19","author":"Gray","year":"1971","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0100","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/0041-008X(78)90163-1","article-title":"Foam cell response in the lung and lymphatic tissues during long-term high-level treatment with erythromycin","volume":"45","author":"Gray","year":"1978","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0105","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/S0006-2952(01)00823-1","article-title":"Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes(1)","volume":"62","author":"Gum","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0110","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/019262339702500111","article-title":"Cationic amphiphilic drug-induced phospholipidosis","volume":"25","author":"Halliwell","year":"1997","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0115","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1021\/tx9003825","article-title":"Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds","volume":"23","author":"Hanumegowda","year":"2010","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0120","first-page":"391","article-title":"The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone","volume":"66","author":"Heath","year":"1985","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0125","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archopht.1982.01030040278015","article-title":"Amodiaquine ocular changes","volume":"100","author":"Hirst","year":"1982","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.tiv.2011.05.026_b0130","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/0006-2952(81)90451-2","article-title":"Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C","volume":"30","author":"Hostetler","year":"1981","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9258(18)89718-6","article-title":"Chloroquine-induced phospholipid fatty liver. Measurement of drug and lipid concentrations in rat liver lysosomes","volume":"260","author":"Hostetler","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2011.05.026_b0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1289\/ehp.7616111","article-title":"Pulmonary changes induced by amphophilic drugs","volume":"16","author":"Hruban","year":"1976","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.tiv.2011.05.026_b0145","first-page":"62","article-title":"Drug-induced and naturally occurring myeloid bodies","volume":"27","author":"Hruban","year":"1972","journal-title":"Lab. Invest."},{"key":"10.1016\/j.tiv.2011.05.026_b0150","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.2174\/156802608786786589","article-title":"Weka machine learning for predicting the phospholipidosis inducing potential","volume":"8","author":"Ivanciuc","year":"2008","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.tiv.2011.05.026_b0155","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/toxsci\/65.2.166","article-title":"Mechanisms of hepatotoxicity","volume":"65","author":"Jaeschke","year":"2002","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0160","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00341016","article-title":"Lipidosis-like alterations in cultured macrophages exposed to local anaesthetics","volume":"55","author":"Jagel","year":"1984","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0005-2760(89)90078-7","article-title":"Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis","volume":"1004","author":"Joshi","year":"1989","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.tiv.2011.05.026_b0170","first-page":"2592","article-title":"Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses","volume":"43","author":"Kacew","year":"1984","journal-title":"Fed. Proc."},{"key":"10.1016\/j.tiv.2011.05.026_b0175","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0022-3565(25)20091-X","article-title":"Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity","volume":"232","author":"Kacew","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2011.05.026_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1093\/toxsci\/kfj067","article-title":"Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential","volume":"90","author":"Kasahara","year":"2006","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0185","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0022-3565(25)10769-6","article-title":"Comparative assessment of poly-l-aspartic and poly-l-glutamic acids as protectants against gentamicin-induced renal lysosomal phospholipidosis, phospholipiduria and cell proliferation in rats","volume":"262","author":"Kishore","year":"1992","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2011.05.026_b0190","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1002\/jbt.2570050407","article-title":"In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats","volume":"5","author":"Kodavanti","year":"1990","journal-title":"J. Biochem. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0195","doi-asserted-by":"crossref","first-page":"6515","DOI":"10.1021\/bi00344a031","article-title":"Mechanism of cationic amphiphilic drug inhibition of purified lysosomal phospholipase A1","volume":"24","author":"Kubo","year":"1985","journal-title":"Biochemistry"},{"key":"10.1016\/j.tiv.2011.05.026_b0200","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.tiv.2009.09.018","article-title":"Prediction of phospholipidosis-inducing potential of drugs by in vitro biochemical and physicochemical assays followed by multivariate analysis","volume":"24","author":"Kuroda","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0205","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/0006-2952(90)90078-Y","article-title":"Aminoglycoside-induced renal phospholipidosis and nephrotoxicity","volume":"40","author":"Laurent","year":"1990","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0210","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0046-8177(90)90076-H","article-title":"Histopathologic analysis of suspected amiodarone hepatotoxicity","volume":"21","author":"Lewis","year":"1990","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0215","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01489178","article-title":"Perhexiline induces generalized lipidosis in rats","volume":"56","author":"Lullmann","year":"1978","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.tiv.2011.05.026_b0220","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/0041-008X(74)90263-4","article-title":"Chlorphentermine-induced lipidosislike ultrastructural alterations in lungs and adrenal glands of several species","volume":"30","author":"Lullmann","year":"1974","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0225","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(78)90435-5","article-title":"Lipidosis induced by amphiphilic cationic drugs","volume":"27","author":"Lullmann","year":"1978","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0230","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF00501610","article-title":"Lipidosis-like ultrastructural alterations in rat lymph nodes after treatment with tricyclic antidepressants or neuroleptics","volume":"286","author":"Lullmann-Rauch","year":"1974","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0235","series-title":"Lysosomes in Applied Biology and Therapeutics","first-page":"49","article-title":"Drug-induced lysosomal storage disorders","author":"Lullmann-Rauch","year":"1979"},{"key":"10.1016\/j.tiv.2011.05.026_b0240","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF02889372","article-title":"Intraalveolar foam cells associated with lipidosis-like alterations in lung and liver of rats treated with tricyclic psychotropic drugs","volume":"19","author":"Lullmann-Rauch","year":"1975","journal-title":"Virchows Arch. B Cell Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0245","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3923\/pjbs.2007.2267.2276","article-title":"Electron microscopic studies on the effect of the diazepam on mouse sartorius muscle","volume":"10","author":"Maisaa","year":"2007","journal-title":"Pak. J. Biol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0250","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0022-3565(25)24510-4","article-title":"Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects","volume":"244","author":"Martin","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2011.05.026_b0255","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1006\/exmp.1995.1002","article-title":"In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages","volume":"62","author":"McCloud","year":"1995","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0260","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1212\/01.wnl.0000194208.08904.0c","article-title":"Natural history of Type A Niemann-Pick disease: possible endpoints for therapeutic trials","volume":"66","author":"McGovern","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.tiv.2011.05.026_b0265","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.tiv.2008.11.010","article-title":"A 96-well flow cytometric screening assay for detecting in vitro phospholipidosis-induction in the drug discovery phase","volume":"23","author":"Mesens","year":"2009","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0270","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.tiv.2010.04.007","article-title":"Screening for phospholipidosis induced by central nervous drugs: comparing the predictivity of an in vitro assay to high throughput in silico assays","volume":"24","author":"Mesens","year":"2010","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s002040050481","article-title":"Functional and subcellular organelle changes in isolated rat and human hepatocytes induced by tetrahydroaminoacridine","volume":"72","author":"Monteith","year":"1998","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0280","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1517\/17425255.2.5.687","article-title":"In vitro assays and biomarkers for drug-induced phospholipidosis","volume":"2","author":"Monteith","year":"2006","journal-title":"Expert. Opin. Drug Metab Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0285","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/0006-2952(88)90553-9","article-title":"Organ-specific, qualitative changes in the phospholipid composition of rats after chronic administration of the antidepressant drug desipramine","volume":"37","author":"Moor","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10565-006-0176-z","article-title":"Validation of an in vitro screen for phospholipidosis using a high-content biology platform","volume":"22","author":"Morelli","year":"2006","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0295","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/toxsci\/kfm157","article-title":"In vitro detection of drug-induced phospholipidosis using gene expression and fluorescent phospholipid based methodologies","volume":"99","author":"Nioi","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/01480540802391229","article-title":"Monitoring the accumulation of fluorescently labeled phospholipids in cell cultures provides an accurate screen for drugs that induce phospholipidosis","volume":"31","author":"Nioi","year":"2008","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0305","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00004836-199104000-00018","article-title":"Reversible hepatitis associated with diclofenac","volume":"13","author":"Ouellette","year":"1991","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.tiv.2011.05.026_b0310","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1126\/science.4035344","article-title":"Defining lipid transport pathways in animal cells","volume":"229","author":"Pagano","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.tiv.2011.05.026_b0315","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/0006-2952(84)90286-7","article-title":"Effect of cationic amphiphilic drugs on the hydrolysis of acidic and neutral phospholipids by liver lysosomal phospholipase A","volume":"33","author":"Pappu","year":"1984","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0320","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0006-2952(85)90183-2","article-title":"Inhibition of purified lysosomal phospholipase A1 by beta-adrenoceptor blockers","volume":"34","author":"Pappu","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0325","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1021\/ci6004542","article-title":"Evaluation of a published in silico model and construction of a novel Bayesian model for predicting phospholipidosis inducing potential","volume":"47","author":"Pelletier","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.tiv.2011.05.026_b0330","first-page":"201","article-title":"Ultrastructural changes in the parenchymal liver cells of rats treated with high doses of rifampicin","volume":"68","author":"Piriou","year":"1987","journal-title":"Br. J. Exp. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0335","first-page":"347","article-title":"Use of physicochemical calculation of pKa and CLogP to predict phospholipidosis-inducing potential: a case study with structurally related piperazines","volume":"55","author":"Ploemen","year":"2004","journal-title":"Exp. Toxicol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0340","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0016-5085(79)80145-6","article-title":"Perhexiline maleate-induced cirrhosis","volume":"76","author":"Pressayre","year":"1978","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2011.05.026_b0345","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0041-008X(89)90054-9","article-title":"A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs","volume":"97","author":"Reasor","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2011.05.026_b0350","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis: are there functional consequences?","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"10.1016\/j.tiv.2011.05.026_b0355","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1164\/ajrccm\/137.3.510","article-title":"Amiodarone-induced phospholipidosis in rat alveolar macrophages","volume":"137","author":"Reasor","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"key":"10.1016\/j.tiv.2011.05.026_b0360","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/14740338.5.4.567","article-title":"Drug-induced phospholipidosis: issues and future directions","volume":"5","author":"Reasor","year":"2006","journal-title":"Expert. Opin. Drug Saf."},{"key":"10.1016\/j.tiv.2011.05.026_b0365","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00352075","article-title":"Morphology of early changes in liver carcinogenesis induced by methapyrilene","volume":"49","author":"Reznik-Schuller","year":"1981","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0370","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/0147-6513(82)90047-1","article-title":"Ultrastructural changes in the liver of animals treated with methapyrilene and some analogs","volume":"6","author":"Reznik-Schuller","year":"1982","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.tiv.2011.05.026_b0375","first-page":"139","article-title":"Inhibition of gentamicin-induced nephrotoxicity by lithium in rat","volume":"8","author":"Samadian","year":"1993","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0380","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1093\/toxsci\/kfh264","article-title":"A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system","volume":"83","author":"Sawada","year":"2005","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0385","first-page":"401","article-title":"High-throughput screening for analysis of in vitro toxicity","volume":"99","author":"Schoonen","year":"2009","journal-title":"EXS"},{"key":"10.1016\/j.tiv.2011.05.026_b0390","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/BF01964942","article-title":"Ultrastructural and biochemical study of the action of benzoctamine and maprotiline on the rat liver","volume":"4","author":"Staubli","year":"1974","journal-title":"Agents Actions"},{"key":"10.1016\/j.tiv.2011.05.026_b0395","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-4800(78)90050-3","article-title":"Some properties of myeloid bodies induced in rat liver by an antidepressant drug (maprotiline)","volume":"28","author":"Staubli","year":"1978","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0400","first-page":"413","article-title":"Morphological and biochemical alteration in the rat liver induced by maprotiline","volume":"25","author":"Tanaka","year":"1975","journal-title":"Acta Pathol. Jpn."},{"key":"10.1016\/j.tiv.2011.05.026_b0405","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1021\/tx00047a006","article-title":"Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status","volume":"8","author":"Tang","year":"1995","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0410","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/17425251003601961","article-title":"Bis(monoacylglycerol)phosphate as a non-invasive biomarker to monitor the onset and time-course of phospholipidosis with drug-induced toxicities","volume":"6","author":"Tengstrand","year":"2010","journal-title":"Expert. Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2011.05.026_b0415","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/(SICI)1520-636X(1996)8:6<411::AID-CHIR1>3.0.CO;2-F","article-title":"Toxic doses of rac-, (-)-(S)- and (+)-(R)-propranolol in rats and rabbits","volume":"8","author":"Toet","year":"1996","journal-title":"Chirality"},{"key":"10.1016\/j.tiv.2011.05.026_b0420","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2131\/jts.31.315","article-title":"Physicochemical and cell-based approach for early screening of phospholipidosis-inducing potential","volume":"31","author":"Tomizawa","year":"2006","journal-title":"J. Toxicol. Sci."},{"key":"10.1016\/j.tiv.2011.05.026_b0425","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0014-4800(70)90087-0","article-title":"Chlorpromazine and the eye of the dog. An electron microscopic study","volume":"13","author":"Tousimis","year":"1970","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.tiv.2011.05.026_b0430","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0887-2333(91)90024-8","article-title":"Potential to induce lamellar bodies and acute cytotoxicity of 6\u2019-alkyl analogues of spectinomycin in primary cultures of rat hepatocytes","volume":"5","author":"Ulrich","year":"1991","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0435","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1021\/jm7013953","article-title":"Assessment of drug-lipid complex formation by a high-throughput Langmuir-balance and correlation to phospholipidosis","volume":"51","author":"Vitovic","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.tiv.2011.05.026_b0440","doi-asserted-by":"crossref","first-page":"G1274","DOI":"10.1152\/ajpgi.2001.280.6.G1274","article-title":"Role of taurine in preventing acetaminophen-induced hepatic injury in the rat","volume":"280","author":"Waters","year":"2001","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tiv.2011.05.026_b0445","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0450","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.tiv.2007.06.017","article-title":"Phase II enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.tiv.2011.05.026_b0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.mrgentox.2011.05.007","article-title":"Development and validation of a high content screening in vitro micronucleus assay in CHO-K1 and HepG2 cells","author":"Westerink","year":"2011","journal-title":"Mutat. Res."},{"key":"10.1016\/j.tiv.2011.05.026_b0460","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0301-0082(99)00036-2","article-title":"Antidepressant-induced lipidosis with special reference to tricyclic compounds","volume":"60","author":"Xia","year":"2000","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.tiv.2011.05.026_b0465","first-page":"1","article-title":"Sphingolipidoses","volume":"114","author":"Yatsu","year":"1971","journal-title":"Calif. Med."}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233311001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T23:59:06Z","timestamp":1741219146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233311001627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":93,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0887233311001627"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2011.05.026","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}